ADIPOQ and breast carcinoma: Clinical studies have linked obesity-related low adiponectin plasma levels with several types of cancer, including breast cancer [40,41,42], and with a more aggressive phenotype (i.e., larger size of tumor, high histological grade, and increased distant metastasis).